<DOC>
	<DOCNO>NCT03092960</DOCNO>
	<brief_summary>The purpose study test flexible lifestyle program design help Latino men make healthy lifestyle change low risk develop diabetes heart disease . The program call HOMBRE ( Hombres con Opciones para Mejorar el Bienestar bajar el Riesgo de Enfermedades crónicas ; English translation : Men choice improve well decrease chronic disease risk ) .</brief_summary>
	<brief_title>The HOMBRE Trial : Comparing Two Innovative Approaches Reduce Chronic Disease Risk Among Latino Men</brief_title>
	<detailed_description>This study comparative effectiveness trial obese Latino men receive , random assignment , HOMBRE intervention minimal intensity intervention . The study design test whether flexible lifestyle program choice program engagement lead well health outcome , compare minimal intensity self-directed lifestyle program . If prove successful , study potential significantly impact health outcome matter Latino men innovative design lifestyle intervention prevent chronic disease .</detailed_description>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<criteria>Latino race BMI &gt; 30 kg/m2 ( ≥27.5 kg/m2 Asian descent ) One metabolic syndrome component ( high triglyceride , blood pressure , fast glucose , central obesity , low HDL cholesterol ) Primary Care Physician approval patient study contact Able willing enroll provide inform consent , i.e. , meet time data collection requirement study , randomize one tow study arm , participate followup 18 month , authorize extraction relevant information form Electronic Health Record . Medical exclusion : Previous diagnosis diabetes diabetes diagnose result fast blood glucose hemoglobin A1c level obtain study screen ; Diagnosis cancer ( nonmelanoma skin cancer ) is/was active treat radiation chemotherapy within past 2 year ; Inability walk without assistance another person ; Severe medical comorbidities require aggressive treatment : e.g. , stage 4 great renal disease , class III great heart failure , unstable coronary artery disease , liver renal failure ; Diagnosis terminal illness and/or hospice care ; Diagnosis bipolar disorder psychotic disorder within last 2 year , currently take mood stabilizer antipsychotic medication Initiation change type dose antidepressant medication within 2 month prior enrollment ( The patient recontacted later cohort his/her regimen stable least 2 month unless person decline participate altogether . ) Have plan undergo bariatric surgery study period Other exclusion : Having reliable telephone service Plan move area study period Family/household member another study participant study staff member Investigator discretion clinical safety protocol adherence reason</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Latino</keyword>
	<keyword>Male</keyword>
</DOC>